Abstract
Gitelman syndrome is a rare, autosomal recessively inherited tubulopathy manifesting with hypokalemia, hypomagnesemia, hypocalciuria, and metabolic alkalosis. Common symptoms include fatigue, myalgia, reduced performance capacity, tetany, paresthesia, and delayed growth. However, as reported in the literature, diagnosis in some patients is prompted by an incidental finding of hypokalemia. GS develops due to mutations in the SLC12A3 gene, which encodes the thiazide-sensitive Na-Cl cotransporter. Many variants in the SLC12A3 gene causing GS have been reported in literature. A new pathogenic homozygous mutation (c.2612G > T), absence of hypomagnesemia, and accompanying autoimmune thyroiditis are remarkable in our patient. There are a few Gitelman syndrome cases that are complicated with autoimmune thyroiditis in the literature. In this study, we present a case of Gitelman syndrome with a novel homozygous mutation and accompanying autoimmune thyroiditis and review of the literature.
Similar content being viewed by others
Abbreviations
- GS:
-
Gitelman syndrome
- BS:
-
Bartter syndrome
- NCC:
-
Na-Cl cotransporter
- CKD:
-
Chronic kidney disease
References
Gitelman H, Graham J, Welt L. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians. 1966;79:221–35.
Hsu Y-J, Yang S-S, Chu N-F, Sytwu H-K, Cheng C-J, Lin S-H. Heterozygous mutations of the sodium chloride cotransporter in Chinese children: prevalence and association with blood pressure. Nephrol Dial Transplant. 2009;24:1170–5.
Aoi N, Nakayama T, Tahira Y, Haketa A, Yabuki M, Sekiyama T, et al. Two novel genotypes of the thiazide-sensitive Na-Cl cotransporter (SLC12A3) gene in patients with Gitelman’s syndrome. Endocrine. 2007;31:149–53.
Dong H, Lang Y, Shao Z, Li L, Shao L. Coexistence of Gitelman’s syndrome and thyroid disease: SLCl2A3 gene analysis in two patients. Chin J Endocrinol Metab. 2010;26:395–8.
Xu X, Sun M, Liu X, Chen H, Xu K, Tang W. Clinical feature and genetic analysis of Gitelman’s syndrome accompanied by autoimmune thyroid disease. Chin J Endocrinol Metab. 2013;29:50–4.
Zha B, Zheng P, Liu J, Huang X. Coexistence of Graves’ Disease in a 14-year-old young girl with Gitelman Syndrome. Clin Endocrinol (Oxf). 2015;83:995–7.
Baldane S, Ipekci SH, Celik S, Gundogdu A, Kebapcilar L. Hypokalemic paralysis due to thyrotoxicosis accompanied by Gitelman’s syndrome. Indian J Nephrol. 2015;25:103–5.
Mizokami T, Hishinuma A, Kogai T, Hamada K, Maruta T, Higashi K, et al. Graves’ disease and Gitelman syndrome. Clin Endocrinol (Oxf). 2016;84:149–50.
Zhou H, Liang X, Qing Y, Meng B, Zhou J, Huang S, et al. Complicated Gitelman syndrome and autoimmune thyroid disease: a case report with a new homozygous mutation in the SLC12A3 gene and literature review. BMC Endocr Disord. 2018;18:82.
Liu S, Ke J, Zhang B, Yu C, Feng Y, Zhao D. A novel compound heterozygous variant of SLC12A3 gene in a pedigree with Gitelman syndrome co-existent with thyroid dysfunction. Endocr Pract. 2018;24:889–93.
Oba T, Kobayashi S, Nakamura Y, Nagao M, Nozu K, Fukuda I, et al. A case of Gitelman syndrome that was difficult to distinguish from hypokalemic periodic paralysis caused by graves’ disease. J Nippon Med Sch. 2019. https://doi.org/10.1272/jnms.JNMS.2019_86-505.
Que C, Zhang J, Chen Y, Hou N. A case of Gitelman syndrome with Hashimoto’s thyroiditis. Shanghai Med J. 2020;43:762–4.
Peng B, Wang H, Yang Y, Xu W, Yuan G. A case of Gitelman syndrome with Graves disease as initial diagnosis. Chin J Intern Med. 2020;59:382–4.
Wang L, Mou L, Zhao H, Zhu H. A case of Gitelman syndrome with hyperthyroidism. Chin J Emerg Med. 2020;29:1375–7.
Song M, Wang N, Li Z, Yin P. Clinical feature and gene mutation analysis of 2 cases of hyperthyroidism complicated with Gitelman syndrome. Jiangsu Med J. 2021;47:424–8.
Yu S, Wang C. Genetic analysis of Gitelman syndrome: co-existence with hyperthyroidism in a two-year-old boy. Endocr Metab Immune Disord Drug Targets. 2021;21:1524–30.
Zhang J-H, Ruan D-D, Hu Y-N, Ruan X-L, Zhu Y-B, Yang X et al. Review and analysis of two Gitelman syndrome pedigrees complicated with proteinuria or Hashimoto’s thyroiditis caused by compound heterozygous SLC12A3 mutations. 2021. https://doi.org/10.1155/2021/9973161
Qin Y-Z, Liu Y-M, Wang Y, You C, Li L-N, Zhou X-Y, et al. Novel compound heterozygous mutation of SLC12A3 in Gitelman syndrome co-existent with hyperthyroidism: a case report and literature review. World J Clin Cases. 2022;10:7483–94.
Xu J, He J, Xu S, Wang R, Peng N, Zhang M. Gitelman syndrome with Graves’ disease leading to rhabdomyolysis: a case report and literature review. BMC Nephrol. 2023;24:123.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
Downie ML, Lopez Garcia SC, Kleta R, Bockenhauer D. Inherited tubulopathies of the kidney: insights from genetics. Clin J Am Soc Nephrol. 2021;16:620–30.
Knoers NV, Levtchenko EN. Gitelman syndrome. Orphanet J Rare Dis. 2008;3:22. https://doi.org/10.1186/1750-1172-3-22.
Riveira-Munoz E, Chang Q, Bindels RJ, Devuyst O. Gitelman’s syndrome: towards genotype-phenotype correlations? Pediatr Nephrol. 2007;22:326–32.
Shen Q, Chen J, Yu M, Lin Z, Nan X, Dong B, et al. Multi-centre study of the clinical features and gene variant spectrum of Gitelman syndrome in Chinese children. Clin Genet. 2021;99:558–64.
Zhong F, Ying H, Jia W, Zhou X, Zhang H, Guan Q, et al. Characteristics and follow-up of 13 pedigrees with Gitelman syndrome. J Endocrinol Invest. 2019;42:653–65.
Fujimura J, Nozu K, Yamamura T, Minamikawa S, Nakanishi K, Horinouchi T, et al. Clinical and genetic characteristics in patients with Gitelman syndrome. Kidney Int Rep. 2019;4:119–25.
Glaudemans B, Yntema HG, San-Cristobal P, Schoots J, Pfundt R, Kamsteeg E-J, et al. Novel NCC mutants and functional analysis in a new cohort of patients with Gitelman syndrome. Eur J Hum Genet. 2012;20:263–70.
Lin S-H, Shiang J-C, Huang C-C, Yang S-S, Hsu Y-J, Cheng C-J. Phenotype and genotype analysis in Chinese patients with Gitelman’s syndrome. J Clin Endocrinol Metab. 2005;90:2500–7.
Lo Y-F, Nozu K, Iijima K, Morishita T, Huang C-C, Yang S-S, et al. Recurrent deep intronic mutations in the SLC12A3 gene responsible for Gitelman’s syndrome. Clin J Am Soc Nephrol. 2011;6:630–9.
Tseng M-H, Yang S-S, Hsu Y-J, Fang Y-W, Wu C-J, Tsai J-D, et al. Genotype, phenotype, and follow-up in Taiwanese patients with salt-losing tubulopathy associated with SLC12A3 mutation. J Clin Endocrinol Metab. 2012;97:E1478–82.
Zeber-Lubecka N, Suchta K, Kulecka M, Kluska A, Piątkowska M, Dabrowski MJ, et al. Exome sequencing to explore the possibility of predicting genetic susceptibility to the joint occurrence of polycystic ovary syndrome and Hashimoto’s thyroiditis. Front Immunol. 2023;14:1193293.
Gong L, Liu B, Wang J, Pan H, Qi A, Zhang S, et al. Novel missense mutation in PTPN22 in a Chinese pedigree with Hashimoto’s thyroiditis. BMC Endocr Disord. 2018;18:76.
Lo MS, Towne M, VanNoy GE, Brownstein CA, Lane AA, Chatila TA, et al. Monogenic Hashimoto thyroiditis associated with a variant in the thyroglobulin (TG) gene. J Autoimmun. 2018;86:116–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared that no conflict of interest exists.
Ethical approval
This article does not contain any studies with human participants performed by any of the authors.
Informed consent
Written informed consent was obtained from the patient for the publication of her clinical data.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Koca, O., Alay, M.T., Murt, A. et al. A novel homozygous SLC12A3 mutation causing Gitelman syndrome with co-existent autoimmune thyroiditis: a case report and review of the literature. CEN Case Rep (2024). https://doi.org/10.1007/s13730-023-00845-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13730-023-00845-z